ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
63 hedge funds and large institutions have $52.9M invested in Adamas Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
52% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 25
Holders
63
Holding in Top 10
1
Calls
$141K
Puts
–
Top Buyers
| 1 | +$2.17M | |
| 2 | +$1.69M | |
| 3 | +$1.36M | |
| 4 |
Two Sigma Investments
New York
|
+$573K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$421K |
Top Sellers
| 1 | -$1.3M | |
| 2 | -$1.08M | |
| 3 | -$945K | |
| 4 |
BOS
Bingham Osborn & Scarborough
San Francisco,
California
|
-$566K |
| 5 |
Jane Street
New York
|
-$476K |